Clinical Trial: A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants With Active Psoriatic Arthritis

U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06807424) titled 'A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants With Active Psoriatic Arthritis' on Jan. 29.

Brief Summary: The purpose of this study is to evaluate the efficacy of icotrokinra compared to placebo in biologic-experienced participants with active psoriatic arthritis (PsA) by assessing the reduction in signs and symptoms of PsA.

Study Start Date: Jan. 09

Study Type: INTERVENTIONAL

Condition: Arthritis, Psoriatic

Intervention: DRUG: Icotrokinra

Icotrokinra will be administered.

DRUG: Placebo

Placebo will be administered.

Recruitment Status: RECRUITING

Sponsor: Jan...